Literature DB >> 18695142

Recent clinical trials: the good, the bad, and the misleading.

Norman M Kaplan.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18695142     DOI： 10.1161/HYPERTENSIONAHA.108.117473

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  3 in total

1.  ONTARGET: How much RAS inhibition is enough?

Authors:  Alan B Weder
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

2.  Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.

Authors:  Nina Vasavada; Rajiv Agarwal
Journal:  F1000 Med Rep       Date:  2009-06-09

3.  Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Hypertension       Date:  2008-12-01       Impact factor: 10.190
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.